Skip to main content
. 2025 Oct 13;35(2):341–364. doi: 10.1007/s00787-025-02826-2

Table 1.

Executive functioning in adolescents with depressive disorders

Study nr Paper Status Mean age
(SD)
Sample size Diagnostic criteria Psychiatric co-occurrences Psychotropic medications EF domain Instrument Results Statistic
1 Baller (2021) MDD (lifetime) MDD:16.87 (2.20) 712

Interview

GOASSESS; DSM-IV-TR

MDD: NR

HC: No

MDD: 30% of the sample

HC: 13%

(Controlled for)

SHIFT PCET (CNB)

MDD Subtype 2 < HC (accuracy & speed)

MDD Subtype 1 > Subtype 2

d  = .50

d  = .76

HC:16.49 (2.84) 712 WM Letter N-Back (CNB)

MDD Subtype 2 < HC (accuracy & speed)

MDD Subtype 1 > Subtype 2

d  = .50

d  = .54

2 Chen (2023) MDD (current) MDD:17.07 (0.80) 29

Interview

MDD: DSM-5; GCI-S ≤ 3

HC: MINI-Kid

NR Yes: % NR SHIFT WCST NS N/A
HC:17 (1.20) 22 WM N-Back MDD < HC (mean time) p  = .016
3 Dell’Acqua (2023;a) MDD (current & lifetime) MDD: 13.6 (1.09) 29

Interview

K-SADS-PL; DSM-IV

MDD: OCD (10%), AD (> 50%) NR INH Flanker Task MDD < HC (speed) p  = .020
HC: 16.2 (2.91) 34 HC: No
4 Diler (2014) MDD (current) MDD: 15.9 (1.10) 10

Interview

K-SADS-PL; DSM-IV-TR)

MDD: AD (60%), ADHD (20%) MDD: 60% INH Go/NoGo NS (reaction times for NoGo responses) p = .56
HC:15.6 (1.2) 10 HC: NR HC: None
5 Fisk (2019) Elevated depressive symptoms (current) Elevated: 14.84 (1.36) 29

Other

MFQ ≥ 27

NR NR INH The HSC

NS (number of errors)

NS (reaction time)

p = . 51

p = .06

HC: 14.65 (1.52) 29 WM The KTT DEP < HC p  = .001
6 Gillespie and Rao (2022) MDD MDD: 16.28 (1.40) 63

Interview

K-SADS-COMP V2.0; DSM-IV

NR No GEC BRIEF-SR MDD < HC p  < .01
HC: 15.60 (1.45) 75 INH CWIT (D-KEFS) NS N/A
7 Hanna (2018)

MDD

(current & lifetime)

MDD: 16.8 (1.4) 36

Interview

K-SADS; DSM-5

MDD: Yes (% NR)

HC: No

MDD: 30%

HC: None

INH Flanker Task NS N/A
HC: 16.2 (1.8) 89
8 Liang (2021)

MDD

(Current & lifetime)

MDD: 17.9 (2.7) 50

Interview

ICD-10

Yes (% NR) MDD: Yes (% NR) WM MCCB—WMS-III SST NS p = .576
HC:17.7 (3.2) 51 HC: NR
9 Onat (2019) MDD (Current & lifetime) MDD-SA: 15.85 (1.02) 32

Interview

K-SADS-PL; DSM-IV

No MDD: Yes (% NR) SHIFT WCST NS N/A
MDD w/o SA: 15.9 (1.23) 30 HC: None INH Stroop Part 1: MDD-SA > HC (time) p  = .029
HC: 15.99 (1.37) 30 Part 3: MDD w/o SA > HC, MDD w/o SA > MDD-SA (correction) p  = .17
Part 4: MDD-SA > HC (time) p  = .015
10 Pan (2020) MDD (Current; First-episode) MDD: 16 28

Interview

SCID; DSM-IV

No No INH SCWT

Part B: MDD < HC

Part C: MDD < HC

p  < .05

p  < .05

HC: 16 24 SHIFT WCST; TMT-B NS+ (perseverative errors) p = .219
11 Peters (2019) Mixed DD MDD-CT: 14.45 (1.54) 22

Interview

K-SADS-PL;

DSM-IV

MDD-CT: AD (> 50%), PTSD (18.2%), ADHD (22.7%)

MDD w/o CT: AD (> 50%), PTSD (5.6%), ADHD (5.6%)

MDD-CT: No

MDD w/o CT: 11%

Parent-rated INH BRIEF-PR

MDD-CT < HC

MDD < HC

d  = .62; p  < .05

d  =  .64

MDD: 14.61 (1.46) 18 HC: No HC: No INH Go/NoGo MDD-CT < HC (accuracy) d  = .54; p  < .05
HC:14.67 (1.37) 30
12 Shebab (2016) MDD (current) MDD: 14.83 (1.63) 24 Interview DAWBA; DSM-IV & ICD-10; CDR-RS ≥ 40 MDD: AD (50%), ADHD (8.3%) MDD: 8.3% INH RVP B’’ (CANTAB) MDD < HC p  < .05
HC: 14.25 (1.59) 24 HC: No HC: No
13 Zhang (2022) MDD (current) MDD-NSSI:16.13 (1.95) 40

Interview

DSM-5

NR No SHIFT TMT-B

MDD-NSSI < HC

MDD < HC

MDD < HC

p  < .01

p  < .01

p  < .05

MDD: 16.67 (1.9) 46 WCST

MDD-NSSI < HC

MDD < HC

p  < .01

p  < .01

HC: 17.07 (3.1) 28

SD Standard deviation, NR Not reported, + after correcting for multiple comparisons, GCI-S Clinical Global Impression-Severity scale, MFQ The Mood and Feelings Questionnaire, MDD Major Depressive Disorder, MDD-SA MDD with suicide attempt, MDD-CT MDD with childhood trauma, MDD-NSSI MDD with non-suicidal self-injury, HCs Healthy controls, WM Working memory

PCET Penn Conditional Exclusion Test, FT Flanker Task, MCCB The MATRICS Consensus Cognitive Battery, HSC The Hayling Sentence Completion task, KTT The Keep Track Task, RPV Rapid Visual Processing, GEC Global Executive Composite score, DST Digit Symbol Test, SCWT Stroop Color and Word Test